home / stock / bntx / bntx articles

BNTX Articles, BioNTech SE

Stock Information
Company Name: BioNTech SE
Stock Symbol: BNTX
Market: NYSE
Website: biontech.de
Menu
BNTX BNTX Quote BNTX Short BNTX News BNTX Articles BNTX Message Board
Get BNTX Alerts

News, Short Squeeze, Breakout and More Instantly...
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment | Benzinga

The European Commission faced criticism from Europe’s second-highest court regarding transparency issues surrounding COVID-19 vaccine contrac...
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B | Benzinga

Wednesday, GSK plc (NYSE:GSK) and CureVac N.V. (NASDAQ:CVAC) announced they have restructured their existing collaboration into a new licensing agr...

London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents | Benzinga

Pfizer Inc. (NYSE:PFE) and Moderna Inc. (NASDAQ:MRNA) are set for more legal battles over their rival COVID-19 vaccines after London’s High C...

AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway | Benzinga

On Wednesday, the FDA approved Epkinly (epcoritamab-bysp) as the first and only T-cell-engaging bispecific antibody administered subcutaneousl...
GameStop And First Solar Were Among The 10 Biggest Large Cap Losers Last Week (June 16-June 22): Are These In Your Portfolio? | Benzinga

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio? GameStop Corp (NYSE:GME) shares lost 18.61% in ...

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment | Benzinga

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its ...

Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? | Benzinga

BioNTech SE’s (NASDAQ:BNTX) partner MediLink Therapeutics (Suzhou) Co., Ltd says the FDA has placed a partial clinical hold on the Phase 1 tr...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season | Benzinga

On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which target...

What's Going On With Novavax Stock? | Benzinga

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at w...

Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, | Benzinga

On CNBC's “Mad Money Lightning Round,” Jim Cramer called Celestica Inc. (NYSE:CLS) “terrific” after the Toronto-based ...
Next 10